ArticleEClinicalMedicine2019

Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer.

Vijay Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.